SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-059322
Filing Date
2014-09-23
Accepted
2014-09-23 16:56:10
Documents
1
Period of Report
2014-09-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3630
  Complete submission text file 0001209191-14-059322.txt   5297
Mailing Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8
Business Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8 011-353-1-649-8521
Horizon Pharma plc (Issuer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 FRANK W. BURR BLVD, SUITE 5 TEANECK NJ 07666
Business Address 300 FRANK W. BURR BLVD, SUITE 5 TEANECK NJ 07666 (201) 836-2308
Vidara Therapeutics Holdings LLC (Reporting) CIK: 0001619143 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35238 | Film No.: 141116485